Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO)
CUSIP: 869367102
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 84,733,230
- Total 13F shares
- 11,616,437
- Share change
- +540,672
- Total reported value
- $127,772,633
- Price per share
- $11.00
- Number of holders
- 64
- Value change
- +$7,088,075
- Number of buys
- 36
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 869367102:
Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SV Health Investors, LLC |
13F
|
Company |
2.2%
|
1,824,542
|
$16,584,000 | — | 30 Sep 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2%
|
1,729,804
|
$15,724,000 | — | 30 Sep 2019 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.3%
|
1,125,579
|
$10,232,000 | — | 30 Sep 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.76%
|
644,019
|
$5,854,000 | — | 30 Sep 2019 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.76%
|
641,268
|
$5,829,000 | — | 30 Sep 2019 | |
| Camber Capital Management LP |
13F
|
Company |
0.71%
|
600,000
|
$5,454,000 | — | 30 Sep 2019 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
525,000
|
$4,772,000 | — | 30 Sep 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.5%
|
422,589
|
$3,841,000 | — | 30 Sep 2019 | |
| BVF INC/IL |
13F
|
Company |
0.41%
|
344,196
|
$3,129,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.38%
|
323,299
|
$2,939,000 | — | 30 Sep 2019 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.33%
|
279,577
|
$2,541,000 | — | 30 Sep 2019 | |
| FMR LLC |
13F
|
Company |
0.26%
|
222,600
|
$2,023,000 | — | 30 Sep 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
155,838
|
$1,417,000 | — | 30 Sep 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.17%
|
144,310
|
$1,312,000 | — | 30 Sep 2019 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.16%
|
139,331
|
$1,264,000 | — | 30 Sep 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
121,424
|
$1,103,000 | — | 30 Sep 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.12%
|
98,542
|
$896,000 | — | 30 Sep 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
92,375
|
$839,000 | — | 30 Sep 2019 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.11%
|
89,081
|
$810,000 | — | 30 Sep 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
48,800
|
$444,000 | — | 30 Sep 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.05%
|
45,660
|
$415,000 | — | 30 Sep 2019 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.05%
|
40,000
|
$364,000 | — | 30 Sep 2019 | |
| Creative Planning |
13F
|
Company |
0.04%
|
31,514
|
$286,000 | — | 30 Sep 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.04%
|
30,786
|
$280,000 | — | 30 Sep 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
30,711
|
$279,000 | — | 30 Sep 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
28,838
|
$262,000 | — | 30 Sep 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
28,234
|
$257,000 | — | 30 Sep 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
26,037
|
$236,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
24,042
|
$219,000 | — | 30 Sep 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
22,839
|
$207,000 | — | 30 Sep 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
22,592
|
$206,000 | — | 30 Sep 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
20,951
|
$190,000 | — | 30 Sep 2019 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.02%
|
17,960
|
$163,000 | — | 30 Sep 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
16,752
|
$152,000 | — | 30 Sep 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
16,300
|
$148,000 | — | 30 Sep 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
13,915
|
$127,000 | — | 30 Sep 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
13,578
|
$123,000 | — | 30 Sep 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
12,732
|
$116,000 | — | 30 Sep 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
11,000
|
$100,000 | — | 30 Sep 2019 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
10,148
|
$92,000 | — | 30 Sep 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
8,690
|
$79,000 | — | 30 Sep 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,870
|
$62,000 | — | 30 Sep 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
5,436
|
$49,000 | — | 30 Sep 2019 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.01%
|
5,080
|
$46,000 | — | 30 Sep 2019 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0%
|
2,851
|
$26,000 | — | 30 Sep 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
2,862
|
$25,000 | — | 30 Sep 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,819
|
$17,000 | — | 30 Sep 2019 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,700
|
$15,000 | — | 30 Sep 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,312
|
$12,000 | — | 30 Sep 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,271
|
$11,553 | — | 30 Sep 2019 |
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) as of Q4 2019
As of 31 Dec 2019,
Sutro Biopharma, Inc. - Common Stock, $0.001 par value (STRO) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,616,437 shares.
The largest 10 holders included
SV Health Investors, LLC, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, Samsara BioCapital, LLC, VV Manager LLC, BlackRock Inc., Tekla Capital Management LLC, Camber Capital Management LP, BVF INC/IL, and VANGUARD GROUP INC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
59
Q4 2019 holders
64
Holder diff
5
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.